Financials
- Market Capitalization 78.54 B
- Employee 15 K
- Founded 1988
- CEO Leonard Schleifer
- Website www.regeneron.com
- Headquarter New York, United States
- FIGI BBG000C734W3
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
18.61
Fiyat/satışlar oranı
5.84
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 118 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 507.00 USD | -0.60% | +0.40% | -2.91% | +24.85% | 128.50 B USD | ||
| 195 | MRNA Moderna, Inc. - Common Stock | 213.74 USD | -5.00% | +5.74% | +47.41% | +711.77% | 85.33 B USD | ||
| 313 | ARGX argenx SE - American Depositary Shares | 812.30 USD | -1.54% | -11.80% | -19.14% | +1.70% | 50.27 B USD | ||
| 359 | RVMD Revolution Medicines, Inc. - Common Stock | 193.95 USD | +2.21% | -7.01% | -4.69% | +250.09% | 41.57 B USD |